Carregant...
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
Renal cell carcinoma (RCC) is considered an immunogenic tumor with a prominent dysfunctional immune cell infiltrate, unable to control tumor growth. Cytokine-based immunotherapies, including interferon-α and interleukin-2, have been used for the treatment of metastatic RCC (mRCC). Long-term response...
Guardat en:
| Publicat a: | Ther Adv Urol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004235/ https://ncbi.nlm.nih.gov/pubmed/27695530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216656811 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|